WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Options
Query Language
Stem
Sort by:
List Length
Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2005035583) ANTIBODY COMPOSITION SPECIFICALLY BINDING TO IL-5 RECEPTOR
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2005/035583 International Application No.: PCT/JP2004/015323
Publication Date: 21.04.2005 International Filing Date: 08.10.2004
IPC:
A61K 39/395 (2006.01) ,A61P 37/08 (2006.01) ,A61P 43/00 (2006.01) ,C07K 16/28 (2006.01) ,C12N 5/10 (2006.01) ,C12N 15/13 (2006.01) ,C12P 21/08 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
395
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
37
Drugs for immunological or allergic disorders
08
Antiallergic agents
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
43
Drugs for specific purposes, not provided for in groups A61P1/-A61P41/108
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
16
Immunoglobulins, e.g. monoclonal or polyclonal antibodies
18
against material from animals or humans
28
against receptors, cell surface antigens or cell surface determinants
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
N
MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
5
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
10
Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
N
MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
15
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
09
Recombinant DNA-technology
11
DNA or RNA fragments; Modified forms thereof
12
Genes encoding animal proteins
13
Immunoglobulins
C CHEMISTRY; METALLURGY
12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
P
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
21
Preparation of peptides or proteins
08
Monoclonal antibodies
Applicants: IIDA, Shigeru; null (UsOnly)
SATOH, Mitsuo; null (UsOnly)
INOUE, Miho; null (UsOnly)
WAKITANI, Masako; null (UsOnly)
UCHIDA, Kazuhisa; null (UsOnly)
NIWA, Rinpei; null (UsOnly)
SHITARA, Kenya; null (UsOnly)
KOIKE, Masamichi; null (UsOnly)
KYOWA HAKKO KOGYO CO., LTD.[JP/JP]; 6-1, Ohtemachi 1-chome Chiyoda-ku Tokyo 1008185, JP (AllExceptUS)
Inventors: IIDA, Shigeru; null
SATOH, Mitsuo; null
INOUE, Miho; null
WAKITANI, Masako; null
UCHIDA, Kazuhisa; null
NIWA, Rinpei; null
SHITARA, Kenya; null
KOIKE, Masamichi; null
Priority Data:
2003-35015908.10.2003JP
2004-12908223.04.2004JP
Title (EN) ANTIBODY COMPOSITION SPECIFICALLY BINDING TO IL-5 RECEPTOR
(FR) COMPOSITION D'ANTICORPS SE LIANT SPECIFIQUEMENT AU RECEPTEUR IL-5
(JA) IL-5受容体に特異的に結合する抗体組成物
Abstract:
(EN) It is intended to provide a composition comprising an antibody molecule which specifically binds to human interleukin-5 receptor (IL-5R) &agr; chain and has an N-glycoside-binding complex sugar chain in the Fc domain, wherein the N-glycoside-binding complex sugar chain is a sugar chain having no fucose attached to N-acetylglucosamine at the reducing end of the sugar chain; a transformant producing this antibody composition; a process for producing the antibody composition; and a drug containing the antibody composition.
(FR) La présente invention concerne une composition comprenant une molécule d'anticorps qui se lie spécifiquement à la chaîne alpha du récepteur humain de l'interleukine 5 (IL-5) et présente une chaîne glucidique complexe se liant au N-glycoside dans le domaine Fc. Ladite chaîne glucidique étant une chaîne glucidique ne présentant aucun fucose relié à la N-acétylglucosamine à son extrémité de réduction. Cette invention concerne également un transformant permettant de produire une telle composition d'anticorps ; un procédé permettant de produire la composition d'anticorps, ainsi qu'un médicament contenant cette composition d'anticorps.
(JA) ヒトインターロイキン-5受容体(IL-5R)α鎖に特異的に結合し、N-グリコシド結合複合型糖鎖をFc領域に有する抗体分子からなる組成物であって、N-グリコシド結合複合型糖鎖が該糖鎖の還元末端のN-アセチルグルコサミンにフコースが結合していない糖鎖である抗体組成物、該抗体組成物を生産する形質転換体、該抗体組成物の製造方法および該抗体組成物を含有する医薬を提供する。
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)